Latest News
New Trial to Investigate Efficacy of Glucocorticoids in Acute IPF Exacerbations
Occupational Asbestos Exposure Alone Not Associated With an Increased Risk of IPF
Elevated Circulating CRP Levels Associated With an Increased Risk of Developing IPF
New Phase 2 Study Set to Evaluate Oral TTI-101 in IPF
New Study Aims to Better Understand Coughing in Pulmonary Fibrosis
Novel 4-Gene Risk Model Could Predict Prognosis in IPF
Pirfenidone Inhibits MRTF Signaling With an Elusive Antifibrotic Mechanism in IPF
Study: More Research Needed on End-Of-Life Discussions With IPF Patients
FDA Grants Fast Track Designation to Experimental Reprogramming Agent for IPF
Latest Clinical Trials
Insights
The Association Between IPF and Lung Cancer: Treatment Options
Research indicates that concomitant idiopathic pulmonary fibrosis worsens clinical outcomes in patients with lung cancer.
COVID-19 Vaccines and the Acute Exacerbation of IPF: A Possible Link?
When it comes to vaccination campaigns, there is an urgent need for message discipline to be strictly maintained. For example, during the COVID-19 pandemic, it was vital that people understood the types of COVID-19 vaccines that have been developed, the rigorous testing process that has been undertaken, and why it is important that all eligible…
Exploring the Relationship Between IPF and Lung Cancer
Idiopathic pulmonary fibrosis (IPF) and lung cancer are often viewed as 2 separate diseases, each with its own pathophysiology. However, recent studies have suggested they are more alike than previously acknowledged. Lung cancer is one of the leading causes of cancer-related deaths across the globe, and patients with IPF are at a higher risk of…
The Relationship Between Air Pollution and Idiopathic Pulmonary Fibrosis
Environmental scientists have been warning us for a long time that climate change and air pollution are having a negative impact on our health. However, medical research attempting to associate environmental factors with the risk of developing certain diseases is scarce. Why is this? Perhaps medical researchers see environmental science as something outside their field…
The Challenges of Using Gene Therapy to Treat Respiratory Disease
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
The Continuing Evolution of Our Understanding of IPF
Various researchers have chronicled how our understanding of idiopathic pulmonary fibrosis has undergone tremendous changes over the years.
The Role of Visual Analog Scales in Understanding the IPF Patient Experience
Researchers explain why they believe visual analog scales are ideal assessment tools for understanding patients’ experiences.
IPF Features
At 40, Orphan Drug Act Enjoys Rare Bipartisan Support
Rare disease advocates are marking the 40th anniversary of the landmark Orphan Drug Act, which has led to over 1100 approvals for new therapies.
The Alliance for Regenerative Medicine Fights for Better Cell, Gene Therapies
The Alliance for Regenerative Medicine aims to help in the development of safe and effective regenerative therapies that can benefit rare disease patients.
Three Lakes Foundation and CHEST Collaborating to Speed Up Diagnosis of IPF
A pulmonary fibrosis foundation and a professional medical association have teamed up to slash the time it takes to diagnose idiopathic pulmonary fibrosis.
Updated Clinical Practice Guidelines Provide Strategies for Diagnosing and Treating IPF
An updated set of clinical practice guidelines has been issued for the diagnosis and treatment of idiopathic pulmonary fibrosis in adults.
Rare Care Podcast
Diagnosing and Treating IPF: Insights From Noah Greenspan, DPT, founder of New York City’s Pulmonary Wellness & Rehabilitation Center.
IPF Meeting Coverage
- Loading...
Loading...
Loading... 
Loading...